2026. An Overview of Biopharmaceutical Difficulties and Furosemide’s Bioavailability Improvement. International Journal of Pharmaceutical Drug Design. 3, 1 (Apr. 2026), 139–143. DOI:https://doi.org/10.62896/ijpdd.3.1.19.